Differences Between Early and Late Onset Adult Depression by Bukh, Jens Drachmann et al.
140  Clinical Practice & Epidemiology in Mental Health, 2011, 7, 140-147   
 
  1745-0179/11  2011 Bentham Open 
Open Access 
Differences Between Early and Late Onset Adult Depression 
Jens Drachmann Bukh
a,*, Camilla Bock
a , Maj Vinberg
a, Ulrik Gether
b and Lars Vedel Kessing
a 
aPsychiatric Center Copenhagen, Denmark  
bDepartment of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Denmark 
Abstract: Background: It is unclear, whether age-of-onset identifies subgroups of depression.  
Aim: To assess the clinical presentation of depression with onset in the early adult age (18-30 years) as compared to  
depression with later onset (31-70 years).  
Method:  A total number of 301 patients with first episode depression were systematically recruited. Characteristics   
including psychiatric co-morbidity, personality disorders and traits, stressful life events prior to onset, family history, and 
treatment outcome were assessed by structured interviews and compared by chi-square tests for categorical data, t-tests for 
continuous parametric data and Mann-Whitney U-test for continuous nonparametric data. Logistic and multiple regression 
analyses were used to adjust the analyses for potentially confounding variables.  
Results: Patients with early onset of depression were characterised by a higher prevalence of co-morbid personality   
disorders, higher levels of neuroticism, and a lower prevalence of stressful life events preceding onset compared to   
patients with later age-of-onset. There were no differences in severity of the depressive episode, treatment outcome or 
family loading of psychiatric illness.  
Conclusion: Early adult onset of depression is associated with co-morbid personality deviances, whereas late onset is  
associated with environmental risk factors. 
Keywords: Depression, age-of-onset, stressful life events, neuroticism, personality disorder. 
INTRODUCTION 
Age-of-onset has been suggested as a valid alternative to 
recurrence and polarity for classifying mood disorders [1]. 
However, it is not clarified, whether age-of-onset identifies 
subgroups of affective disorders or how to define the cut-off 
age. The majority of previous studies on characteristics of 
depression according to age-of-onset fall in two categories: 
Studies that have evaluated childhood or adolescent onset 
depression in comparison with adult depression (typically 
cut-off of 18-21 years) [2-5] and studies that have compared 
patients with late-life onset of depression to patients with 
earlier onset (typically a cut-off of 55-65 years) [6-10]. The 
age groups used in these studies are motivated by hypotheses 
of different aetiologies of depression, for example an   
increased familial loading for depression among patients 
with pre-adult depressions [5] and more vascular risk factors 
among patients with late-life depressions [11]. In contrast, 
there is a paucity of investigations of the impact of age-of-
onset among patients with onset of depression in the ages 
between these extremes [12]. Moreover, previous studies 
have included mixed samples of patients with single and 
recurrent depressions. Consequently, age–of-onset has been 
assessed retrospectively among patients who might have   
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experienced a number of episodes in the intervening time 
period between onset and assessment. This method implies a 
risk of confounding, since, as stated by the authors of the 
STAR*D study, “some of the factors ostensibly related to 
age of onset might actually be accounted for by current age, 
duration of illness and gender” [4]. Additionally, recall bias 
may influence the assessment of a number of variables, for 
example the experience of stressful life events prior to onset, 
due to the long time intervals between the time of onset and 
the time of the examination. 
The present study aimed to assess the validity of a   
phenomenological distinction between depression with   
age-of-onset between 18 and 30 years (hereafter designated 
early adult depression (EAD)) and depression with later ages 
at onset (31-70 years, hereafter designated late adult depres-
sion (LAD)) by comparing a range of clinical and socio-
demographic characteristic between these two groups. There 
is no consensus about the appropriate cut-off ages in previ-
ous studies assessing the impact of age-of-onset. In one 
study of 198 non-psychotic and non-melancholic outpatients 
[31], the median age at onset of the first depressive episode 
(29 years) was used to define early onset as compared to late 
onset depression. The clinical differences between the two 
groups (early onset depressions had significantly more recur-
rences, atypical features, irritability, interpersonal sensitivity 
and more frequently a family history of mood disorders) 
gradually disappeared as the age cut-off was increased to 40, 
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dence for a cut-off age around 30 years. Hence, this was also 
used in the present study. In order two reduce recall bias and 
confounding by the history of depression among participants, 
we included only patients with a recent onset of the first life-
time depressive episode, sytematically recruited by means of 
the Danish Psychiatric Central Research Register [13], which 
was also used to characterise non-participants in the study.  
MATERIALS AND METHODOLOGY 
The Register 
The Danish Psychiatric Central Research Register is a 
nation-wide registration of all psychiatric hospitalisations 
and outpatient contacts (patients in ambulatory care or com-
munity psychiatry centres) in Denmark [13]. The register 
comprises information on treatment settings, duration of con-
tact to psychiatric care, and psychiatric diagnoses (from 
1994 January 1 according to The International Classification 
of Diseases, 10th Revision, ICD-10 [14]. The registration is 
based on a unique person identification number assigned to 
all inhabitants in Denmark (Civil Person Registration num-
ber), thus previous contacts to psychiatric services can be 
established with great certainty irrespective of changes in 
names or addresses. General practitioners and psychiatrists 
in private practice do not report to the register. No private 
psychiatric hospitals are operating in Denmark.  
The Sample 
The study sample was defined as all outpatients (patients 
in hospital ambulatory care and community psychiatry cen-
tres) and inpatients (patients admitted during daytime or 
overnight to a psychiatric hospital) with the diagnosis of a 
single depressive episode (ICD-10, code DF32-32.9) re-
ported to the Danish Psychiatric Central Research Register 
following the first contact ever to a psychiatric hospital in 
eastern Denmark (Sealand (Sjælland)) and aged 18-70 years 
at the time of discharge. This area comprises approximately 
2.4 million inhabitants corresponding to 44% of the total 
Danish population. Patients were sampled consecutively 
from the register every second month in a period from 2005 
June 1 through 2007 May 31 and invited to participate in the 
study 1-3 months after discharge. In order to obtain a homo-
geneous sample, we included only individuals of Danish 
ethnicity (the proband as well as both parents were born in 
Denmark and no grandparents were born outside Europe). 
Since we intended to evaluate response to antidepressant 
treatment, individuals who never received antidepressant 
medication (for at least one week), were excluded. The only 
exclusion criteria were significant physical illness, dementia 
or mental retardation.  
The Danish Ministry of Health, The Danish Ethic Com-
mittee (KF 01.209/04) and the Data Inspection approved the 
study. The investigation was conducted in accordance with 
the latest version of the Declaration of Helsinki. All partici-
pants gave written informed consent. 
Interviews and Questionnaires 
The interviews were conducted by two experienced 
medical doctors (CB and JDB) using standardized semi-
structured interviews. The interviewers conducted co-ratings 
of 10 interviews in a pilot study and of additional 16 inter-
views during the 2-year inclusion period. 
In order to validate the clinical diagnoses reported to the 
register, psychiatric diagnoses according to ICD-10 criteria 
were obtained using the Schedules for Clinical Assessment 
in Neuropsychiatry (SCAN) [15]. The diagnostic evaluation 
was based on the interview with the patient and data from 
case reports, which were available for 79.1 % of the partici-
pants. ICD-10 diagnoses according to the SCAN interview 
were established for the episode leading to psychiatric hospi-
tal contact and for the lifetime before. Both interviewers fol-
lowed a WHO-certified course in the use of the SCAN. The 
reliability coefficient (agreement of the diagnosis of a single 
depressive episode) was 1.0. Atypical features were estab-
lished in terms of reversed vegetative symptoms (overeating 
and oversleeping), which has been proposed as a simple 
definition of atypical depression [16]. 
Diagnoses of personality disorders (PD) were assessed 
according to DSM-IV criteria using the Structured Clinical 
Interview for DSM-IV Axis II Personality Disorders (SCID-
II) [17]. The reliability coefficient (agreement of the diagno-
sis of a personality disorder of any kind) was 0.76.  
The presence of life events in a period of six months 
prior to onset of the depressive symptoms was assessed by 
means of the Interview for Recent Life Events (IRLE) [18], 
which specifies 64 different life events in nine areas com-
prising work, education, financial conditions, health, be-
reavement, migration, courtship and cohabitation, legal mat-
ters, family and social affairs, and marital relations. For each 
life event, detailed information was recorded in order to as-
sess the time of occurrence, the independency of the depres-
sive state (rated from almost certainly independent to almost 
certainly dependent on a five point scale) and the negative 
impact of the event (rated from no negative impact to severe 
negative impact on a five point scale). In line with the guide-
lines for the use of IRLE, the evaluation of negative impact 
was based on an objective judgement made by the inter-
viewer taking into account the individual and contextual cir-
cumstances. Stressful life events (SLE) were defined as 
those events, which were rated certainly or most likely inde-
pendent of the depression (an independency score of 1-2 in 
IRLE) and of moderate to severe negative impact (an impact 
score of 1-3 in IRLE). The reliability coefficient between the 
to interviewers (agreement of the presence of one or more 
stressful life events) was 0.82. 
A complete medical treatment history was evaluated us-
ing the Treatment Response to Antidepressants Question-
naire (TRAQ) [19]. Each antidepressant medication and each 
combination of different antidepressants or add-on treat-
ments with other classes of drugs (lithium, anticonvulsants 
or neuroleptics) were assessed as separate antidepressant 
trials. For each trial the duration, dosages, setting, compli-
ance and outcome (rated from no effect to very good effect 
on a five-point scale) were recorded.  
The family history of psychiatric illness, substance abuse 
and suicide among first and second-degree relatives were 
evaluated using a modification of the Family History Method 
[20]. The reliability coefficient (agreement of a family his-
tory of depression among first-degree relatives) was 0.91. 142     Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7  Bukh et al. 
Severity of depressive symptoms at the time of the inter-
view was assessed using the 17-item Hamilton Depression 
Rating Scale (Ham-D 17) [21] and the 21-item Beck Depres-
sion Inventory (BDI 21) [22]. Moreover, the participants 
completed questionnaires regarding personality traits (Ey-
senck Personality Questionnaire, EPQ [23]) and anxiety 
symptoms (the 14-item Anxiety Subscale of the Symptom 
Rating Scale for Depression and Anxiety [24]). Only com-
plete answers of the questionnaires were included in the 
analyses (BDI: N=285, Anxiety Subscale: N=290, EPQ: 
N=243). 
Outcome was assessed in two levels: 1) remission fol-
lowing the first adequate antidepressant trial and 2) Ham-D 
17 score and BDI 21 score at endpoint (the time of examina-
tion), that is the final outcome of the overall treatment as 
given in clinical practice. An adequate antidepressant trial 
was defined in accordance with the Antidepressant Treat-
ment History Form (ATHF) by Sackheim [25] as treatment 
with an antidepressant drug for > 4 weeks in a sufficient 
dosage (corresponding to a score of 3 or above in ATHF) 
and in addition with > 85% compliance (corresponding to a 
score of 4 in the TRAQ). Remission was defined as a HAM-
D 17 score  7 at the interview as well as a response score of 
4 or above in TRAQ. Non-remission was established, when 
the initial antidepressant treatment has been discontinuated 
because of insufficient effect. Discontinuation was defined 
as either a shift to another antidepressant or add-on treatment 
with lithium, another antidepressant drug (except for mian-
serin in doses not higher than 20 mg and amitriptylin or nor-
triptylin in doses not higher than 25 mg per day), or an antip-
sychotic drug in a dosage equivalent to 100 mg chlorpromaz-
ine per day or above.  
Onset of depression, defined as the time point, when the 
patient first experienced significant depressive symptoms, 
was established during the SCAN interview. If it was impos-
sible to determine a more precise date of onset, onset was 
defined as the time, when the patient was seeking profes-
sional care because of depressive symptoms for the first 
time. 
Non-Participants 
Register information on age, gender, treatment settings 
(inpatient/outpatient), diagnoses, and the duration of psychi-
atric hospital contact was available for all participants as 
well as non-participants in the study. Additional information 
was collected for non-participants on ethnicity, adverse life 
events prior to onset of depression, treatment with antide-
pressants, and overall subjective improvement during the 
treatment period (in three categories “yes”, “no”, and “un-
sure/perhaps”) by a structured telephone interview or alterna-
tively by a questionnaire including the same questions, 
which was posted to all non-participants.  
Statistical Analysis 
Patients with EAD and LAD were compared with regard 
to demographic and clinical variables using chi-square tests 
for categorical data, t-tests for continuous parametric data 
and Mann-Whitney U-test for continuous nonparametric 
data. We used logistic and multiple regression analyses to 
test the effects of age-of-onset adjusted for the effect of gen-
der, and other potentially confounding variables on catego-
rized and continuous outcome variables, respectively.  
Because of the large number of variables tested in uni-
variate and adjusted analyses, p-values (two-sided) < 0.005 
were regarded to indicate statistical significance, and p-
values (2-sided) between 0.005 and 0.05 were regarded to 
indicate a trend. The tests were performed with SPSS 15.0 
for windows (Release 15.0.0 (6 sep 2006)).  
RESULTS 
Participants and Non-Participants 
In total, 1486 individuals with the main diagnosis of a 
single depressive episode were sampled from the register, 
480 individuals were excluded (owing to data protection 
(N=78), non-pharmacological treatment (N=78), non-Danish 
ethnicity (N=291), death (N = 9), disability (N = 14), or mi-
gration (N = 10)), 399 participants took part in the full face-
to-face interview (participation rate 39.7%) and 238 indi-
viduals (39.2% of the non-participants) completed the short 
questionnaire or telephone interview. The participants did 
not differ from the non-participants with respect to age at 
discharge, severity of depression (mild, moderate or severe 
according to register diagnoses), setting (in- or outpatients), 
duration of hospital contact, prevalence of SLE or overall 
subjective improvement during treatment (p>0.1). An excess 
of women participated in the study (64.9% vs. 58.5%, 
p=0.04). Among the 399 participants, the diagnosis of a sin-
gle depressive episode according to ICD-10 was established 
by the SCAN interview for 301 individuals, who constituted 
the sample for further analyses. The remaining participants 
obtained diagnoses of recurrent depression (11.0%), bipolar 
disorder (3.3 %), dysthymia (0.5%), schizophrenia (1.0 %) and 
various other diagnoses (8.8 %)). 
Socio-Demographic Characteristics According to Age of 
Onset 
Ninety-nine of the 301 participants (33%) had onset of 
the first depressive episode at the age of 30 or below. Table 
1 presents socio-demographic characteristics according to 
age of onset. As can be seen, more females presented with 
EAD compared to male patients. There was a higher propor-
tion of the patients with EAD who were employed or stu-
dents and a higher proportion who were living alone as com-
pared to patients with LAD. 
Treatment Characteristics According to Age of Onset 
The majority of participants had received more than one 
antidepressant trial defined as treatment with different anti-
depressants, different combinations of antidepressants, or 
different add-on treatments with lithium, anticonvulsants or 
neuroleptics. There were no significant differences between 
the patients with EAD and LAD in the total number of anti-
depressant trials (1 trial: 48.5% vs. 38.6%, 2 trials: 25.3% vs. 
23.3%, 3 trials: 14.1% vs. 20.8%, >4 trials: 12.2% vs. 17.3%, 
p=0.4), in the type of drug given as first-line treatment (se-
lective serotonin reuptake inhibitors: 76.8% vs. 62.9%, sero-
tonin and norepinephrine reuptake inhibitors: 12.1% vs. 
14.4%, noradrenergic and specific serotonergic antidepres-
sant: 8.1% vs. 19.2%, tricyclic antidepressants: 1.1% vs. 
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Table 1. Socio-Demographic Characteristics of the Participants, Totally and by Age-Of-Onset 
Characteristic  Total 
(N=301) 
Age < 30 Years 
(N=99) 
Age > 30 Years 
(N=202) 
P 
1 
Gender (female), N (%)  199 (66.1)  84 (84.8)  115 (56.9)  <0.0005 
Work status
2, N (%) 
Unemployed, sick leave or retired 
Employed or student 
67 (24.2) 
210 (75.8) 
7 (7.6) 
85 (92.4) 
125 (67.7) 
60 (32.4) 
<0.0005 
Marital status
3, N (%) 
Married/living together 
Living alone 
148 (54.2) 
125 (45.8) 
31 (36.0) 
55 (64.0) 
117 (62.6) 
70 (37.4) 
<0.0005 
1) P-values (2-sided) in analyses comparing patients with early and late onset (
2-test). 
2) Data missing from 24 patients.
 
3) Data missing from 28 patients.
 
Table 2. Clinical Characteristics of 301 Patients with First Episode Depression, Totally and by Age-of-Onset 
Characteristic  Total 
(N=301) 
Age < 30 Years 
(N=99) 
Age > 30 Years 
(N=202) 
P 
1 
B /OR (95% CI)
 2 
Early vs Late Onset  
(Adjusted for Gender) 
P 
3 
Severity of depression
4, N (%) 
 Mild 
 Moderate 
 Severe 
 
73 (24.3) 
161 (53.5 
67 (22.3) 
 
19 (19.2) 
56 (56.6) 
24 (24.2) 
 
54 (26.7) 
105 (52.0) 
43 (21.3) 
 
0.4 
 
0.6 (0.3-1.2) 
0.8 (0.4-1.5) 
1 
 
0.1 
0.5 
Melancholic features
4, N (%)  196 (65.1)  58 (58.6)  138 (68.3)  0.1  0.7 (0.4-1.2)  0.2 
Psychotic features
4, N (%)  13 (4.3)  4 (4.0)  9 (4.5)  0.9  1.4 (0.4-5.0)  0.6 
Suicidal ideations
4, N (%)  194 (64.5)  69 (69.7)  125 (61.9)  0.2  1.6 (0.9-2.7)  0.09 
Atypical features
4, N (%)  11 (3.7)  10 (10.1)  1 (0.5)  <0.0005  15.4 (1.9-122.9)  0.01 
Psychiatric co-morbidity
4, N (%) 
 Anxiety/OCD 
 Alcohol abuse 
 Drug abuse 
 Somatoform/eating disorders 
 
143 (47.5) 
45 (15.0) 
22 (7.3) 
14 (4.7) 
 
53 (53.5) 
7 (7.1) 
14 (14.1) 
8 (8.1) 
 
90 (44.6) 
38 (18.8) 
8 (4.0) 
6 (3.0) 
 
0.1 
0.007 
0.001 
0.05 
 
1.2 (0.7-2.0) 
0.4 (0.2-0.9) 
4.1 (1.6-10.8) 
2.1 (0.7-6.4) 
 
0.4 
0.03 
0.004 
0.2 
Personality disorders
5, N (%) 
 Any personality disorder 
 Cluster A 
Paranoid 
 Schizotypal 
Schizoid  
Cluster B 
 Antisocial 
 Borderline 
Histrionic 
 Narcissisitic  
 Cluster C 
Evasive 
Dependent 
Obsessive-compulsive 
 Depressive 
 
96 (31.9) 
3 (1.0) 
3 (1.0) 
3 (1.0) 
9 (3.0) 
35 (11.6) 
0 
1 (0.3) 
30 (10.0) 
12 (4.) 
19 (6.3) 
26 (8.6) 
 
55 (55.6) 
2 (2.0) 
2 (2.0) 
2 (2.0) 
5 (5.1) 
26 (26.3) 
0 
0 
14 (14.1) 
9 (9.1) 
10 (10.1) 
14 (14.1) 
 
41 (20.3) 
1 (0.5) 
1 (0.5) 
1 (0.5) 
4 (2.0) 
9 (4.5) 
0 
1 (0.5) 
16 (7.9) 
3 (1.5) 
9 (4.5) 
12 (5.9) 
 
<0.0005 
0.2 
0.2 
0.2 
0.1 
<0.0005 
- 
0.5 
0.09 
0.002 
0.06 
0.02 
 
4.8 (2.8-8.3) 
2.8 (0.2-31.1) 
8.2 (0.7-105.7) 
4.8 (0.4-62.1) 
3.5 (0.1-1.8) 
6.2 (2.7-14.2) 
- 
- 
1.6 (0.7-3.4) 
9.8 (2.3-41.0) 
3.4 (1.2-9.4) 
2.0 (0.9-4.7) 
 
<0.0005 
0.4 
0.1 
0.2 
0.09 
<0.0005 
- 
- 
0.3 
0.002 
0.02 
0.1 
Personality traits
6, mean (SD) 
 Neuroticism-score 
 Extroversion-score 
 
11.6 (6.3) 
11.5 (5.4) 
 
14.0 (5.5) 
11.4 (5.7) 
 
10.5 (6.3) 
11.5 (5.3) 
 
<0.0005 
0.9 
 
-2.7 (-4.4- -1.0) 
-0.05 (-1.6-1.5) 
 
0.002 
1.0 
Anxiety score
7, mean (SD)  10.2 (6.2)  10.7 (5.7)  10.0 (6.4)  0.4  0.1 (-1.4-1.7)  0.9 
Family history of psychiatric illness in 1. 
generation, N (%) 
 Depression 
 Any psychiatric illness 
 
87 (28.9) 
199 (66.1) 
 
33 (33.3) 
67 (67.7) 
 
54 (26.7) 
132 (65.3) 
 
0.2 
0.7 
 
1.4 (0.8-2.5) 
1.0 (0.6-1.6) 
 
0.20 
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Table 2. cont….. 
Characteristic  Total 
(N=301) 
Age < 30 Years 
(N=99) 
Age > 30 Years 
(N=202) 
P 
1 
B /OR (95% CI)
 2 
Early vs Late Onset  
(Adjusted for Gender) 
P 
3 
Family history of suicide in 1. generation, N (%)  10 (3.3)  2 (2.0)  8 (4.0)  0.4  0.5 (0.1-2.3)  0.3 
One or more stressful life events
8, N (%)  189 (62.8)  46 (46.5)  143 (70.8)  <0.0005  0.4 (0.2-0.7)  0.001 
1) P-values (2-sided) in univariate analyses comparing patients with early and late onset (
2-test categorical data and t-test for continuous data). 
2) Correlation coefficients in multiple regression models / odds-ratios in logistic regression models; the effect of age-of-onset adjusted for the affect of gender. 
3) P-values (2-sided) in the regression models. 
4) According to Schedules for Clinical Assessment in Neuropsychiatry (SCAN).
 
5) According to The Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II).
 
6) According to Eysenck Personality Questionnaire (EPQ). 
7) According to Symptom Rating Scale for Depression and Anxiety, Anxiety Subscale. 
8) According to Interview of Recent Life Events (IRLE).
 
 
in total duration of treatment (median duration: 8.0 month 
(quartiles 5.0-13.8) vs. 7.5 month (quartiles 5.3-13.0 ), 
p=0.7), but there was a trend for more patients with LAD 
being treated in inpatient settings (inpatients: 52.5% vs. 
64.9%, p=0.04). 
Clinical Characteristics of Patients According to   
Age-of-Onset 
Table 2 presents clinical characteristics according to age 
at onset, unadjusted and adjusted for the effect of gender. 
Comparison of patients with EAD and LAD revealed several 
significant differences between the groups. As can be seen 
from Table 2, the patients with EAD were characterized by a 
substantial higher prevalence of any co-morbid personality 
disorder (PD), also when adjusted for the effect of gender. 
This difference between the age groups reached significance 
in separate analyses comparing the prevalence of dependent 
PD (adjusted p = 0.002) and borderline PD (adjusted p < 
0.0005), respectively. Also, there was a trend for a higher 
prevalence of obsessive-compulsive PD among patients with 
EAD when adjusted for the effect of gender (adjusted p = 
0.02). Further, a higher level of neuroticism characterized 
EAD. Drug abuse (of any kind inclusive cannabis) was more 
frequent among patients with EAD; on the other hand, there 
was a trend for less prevalent alcohol abuse among patients 
with EAD. The experience of stressful life events prior to the 
onset of depression was significantly less prevalent among 
patients with EAD compared to patients with LAD. Severity 
of depression as reflected in the ICD-10 diagnoses obtained 
by SCAN interview did not differ between patients with 
EAD and LAD, and subdivisions according to symptomatol-
ogy revealed differences neither in melancholic or psychotic 
features, nor in the prevalence of suicidal ideations, though 
there was a trend for more patients with EAD presenting 
atypical features. Moreover, there was no gender difference 
in family history of psychiatric illness or suicide.  
In order to examine the positive findings in more details, 
we performed additional multivariate analyses. Even though 
the severity of depressive symptoms was rather low at the 
time of interview (mean Ham-D 17 score was 9.3 (S.D. 6.2), 
and 44.5% of the participants had a Ham-D 17 score < 7), 
remaining depressive symptoms could have influenced the 
assessment of PD and the reporting of stressful life events. 
Thus, we analysed the combined effects of age-of-onset, 
gender, and Ham-D score at the time of interview on the 
prevalence of PD and SLE, respectively, in logistic regres-
sion analyses, which revealed only minor changes in the ef-
fects and significance levels (results not presented). Since 
impulsive behaviour, e.g. by drug abuse, is a criterion for 
borderline PD, we tested whether the excess of drug abuse 
among young patients was independent of this diagnosis. 
Including co-morbidity of borderline PD in the regression 
analysis together with age-of-onset and gender as independ-
ent variables revealed a smaller and non-significant effect of 
age-of-onset on the prevalence of drug abuse (OR=2.8, 
95%CI: 1.1-7.1, p=0.03), indicating that the excess of drug 
abuse among patients with EAD was partly attributable to 
more prevalent borderline PD in this group. 
Clinical Outcome According to Age-of-Onset 
Among the non-remitters, 28 individuals had never re-
ceived an adequate antidepressant trial according to the defi-
nition used, and consequently they were excluded from the 
analyses of remission following the first-line treatment. Two 
patients, who initially got ECT, were also excluded, leaving 
a total number of 271 individuals for these analyses. All of 
the 301 participants were included in the analyses of the final 
outcome expressed as Ham-D 17 score at endpoint (the time 
of the interview), and all of the 285 participants, who com-
pleted the BDI 21, were included in the analyses of outcome 
expressed as BDI score. As can be seen from Table 3, age-
of-onset did not influence the rate of remission on first-line 
treatment. Patients with EAD reported more depressive 
symptoms at endpoint as measured on BDI, though when 
adjusted for gender this difference only reached borderline 
significance (p = 0.008). In contrast, the symptom severity as 
measured on HAM-D did not differ between the two age 
groups. 
  Because of the difference in symptom severity as as-
sessed by BDI and HAM-D, respectively, we considered that 
the reporting of subjective symptoms in BDI could reflect 
personality traits rather than a state phenomenon. Therefore, 
we included neuroticism-score together with age-of-onset 
and gender in a multiple regression analyses with BDI-score 
as the dependent variable. In this model, the effect of age-of-
onset on BDI-score was no longer significant (B= -1.2, 95% 
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DISCUSSION 
Main Results 
Patients with onset of depression in the early adult age 
(<30 years) were characterised by a substantially higher 
prevalence of co-morbid dependent PD and borderline PD, a 
higher level of neuroticism, a lower prevalence of stressful 
life events experienced during a six month period preceding 
onset, and, further, a trend towards a higher prevalence of 
atypical features compared to patients with later age-of-
onset. The patients with early onset reported more subjective 
depressive symptoms (BDI 21 score) after treatment, how-
ever this difference disappeared after adjustment for the ef-
fect of gender and neuroticism. Further, there was no differ-
ence in the rate of remission following first-line antidepres-
sant treatment and no difference in the symptom severity at 
endpoint assessed with Ham-D 17. Moreover, age-of-onset 
did not have any impact on severity of the depressive epi-
sode or on the prevalence of a family history of psychiatric 
illness. Patients with early onset had more drug abuse, but 
this difference seemed to be – at least in part – attributable to 
a higher prevalence of co-morbid borderline PD in this 
group. 
Advantages of the Study 
The inclusion of patients with recent onset of a single de-
pressive episode, exclusively, is an important advantage. 
Further, the study participants were systematically recruited 
and register data on all non-participants plus additional in-
formation from questionnaires or telephone interviews on 39 
% of the non-participants was included. Based on these data, 
our sample seems to be representative for a Danish popula-
tion of patients in psychiatric hospital care diagnosed with a 
single depressive disorder. It is often supposed, that the es-
timated prevalence of PD among patients with depression 
may be influenced by the presence of depressive symptoms 
[26], even though this has not been found by all authors [27]. 
The same concern may apply to the evaluation of life events 
due to recall bias. We conducted the interviews some time 
following discharge (median 147 days, quartiles 119-184 
days), that is to say, apart from the acute depressive state, 
thereby probably reducing this source of error. Further, we 
adjusted the regression analyses for the effect of Ham-D 17-
score at the time of the interview. Treatment outcome was 
assessed in two stages: Outcome on first line antidepressant 
treatment as well as the final outcome following one or sev-
eral antidepressant trials. These outcome measures reflect 
clinical reality and could be regarded as more relevant to 
clinical practice than the short-term outcome of randomised, 
controlled trials. Finally, we used comprehensive interviews 
to ensure a high validity of our data and a multidimensional 
approach, which enabled us to characterise the depressive 
disorder on a broad range of clinical variables and to adjust 
positive associations for the effects of potential confounders. 
Limitations of the Study 
Even though we included the participants shortly after 
onset of depression, SLE and personality factors were still 
assessed retrospectively and recall bias cannot be excluded. 
Remission on first-line treatment was also evaluated retro-
spectively. Further, the interviewers were not blinded to the 
age of the participants. We considered only recent SLE, since 
it has been shown, that the effect of environmental adversities 
is quickly declining with time [28]. More distant SLE, chronic 
stress, childhood adversities, social support or positive life 
events, which might also be associated with age-of-onset, were 
not evaluated. SLE were assessed in a wide sense. It is possible 
that age-of-onset is more or less associated with specific sub-
types of SLE. The group of patients with LAD represent a 
larger age span than the EAD group and might be more hetero-
geneous than the younger patients, since the older patients in 
the LAD group probably present greater brain atrophy and 
poorer physical health and also face the psychosocial factors 
of old age. Finally, and probably most importantly, we investi-
gated a sample of patients referred to psychiatric hospital care, 
and consequently our findings cannot be generalized to patients 
with milder depressions treated in primary care. 
Methods of Previous Studies 
All studies of clinical differences between early and late 
onset depression have included mixed samples of patients 
with various numbers of subsequent depressive episodes. 
This method implies three important limitations. Firstly, de-
termining the onset of the first depressive episode retrospec-
tively is uncertain due to the time interval between age at 
onset and current age and there seems to be a substantial risk 
of recall bias. Secondly, since the participants with earlier 
onset are usually younger at entry into the studies [12, 29-
31] and have a longer total length of illness and more de-
pressive episodes [12], it becomes difficult to distinguish the 
effect of current age and different courses of illness from 
differences related to age-of-onset per se. Thirdly, there is no 
control of selection, when patients are included at some later 
point in the course of illness. This will inevitably result in 
Table 3. Outcome of First Episode Depression, Totally and by Age-Of-Onset 
Characteristic 
Total 
(N=301) 
Age < 30 Years  
(N=99) 
Age > 30 Years 
(N=202)  P 
1 
B /OR (95% CI)
 2 
Early vs late Onset 
(Adjusted for Gender) 
 
P 
3 
Remission on first-line treatment, N (%)  79 (29.2)  27 (31.8)  52 (28.1)  0.5  1.3 (0.7-2.4)  0.4 
Mean Ham-D 17 score at endpoint (S.D.) 
4  9.3 (6.2)  8.9 (5.8)  9.4 (6.3)  0.5  0.6 (-0.9-2.2)  0.4 
Mean BDI 21 score at endpoint (S.D.) 
5  15.3 (9.9)  18.4 (10.3)  13.8 (9.4)  <0.0005  -3.4 (-5.8- -0.9)  0.008 
1) P-values (2-sided) in univariate analyses comparing patients with early and late onset (
2-test categorical data and t-test for continuous data) 
2) Correlation coefficients in multiple regression models / odds-ratios in logistic regression model; the effect of age-of-onset adjusted for the affect of gender 
3) P-values (2-sided) in the regression models
 
 4) 17-item Hamilton Depression Rating Scale (Ham-D 17) 
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selection bias; for example, it seems reasonable to believe, 
that patients with many recurrences, a poor response to 
treatment, more pronounced co-morbidity or more serious 
psychosocial consequences of the illness have a higher ten-
dency to seek professional care and therefore a higher chance 
of being enrolled in clinical investigations. None of the stud-
ies has presented data on non-participants. Thus, the influ-
ence of selection on the findings cannot be further estimated. 
The present study was designed to oppose these methodo-
logical problems by using a systematic recruitment proce-
dure and by investigating depression at onset (i.e. patients 
with first lifetime depressive episode). 
Results of Previous Studies 
The majority of studies on age differences in the phe-
nomenology of depression have focused either on childhood 
and adolescent depression (onset before 18-21 years) (e.g. 
[2-5]) or on late-life depression (onset after 55-65 years) 
(e.g. [6-10]). A few studies have used a cut-off age of 25-35 
years, hence grouped some cases of early adult onset depres-
sion together with the childhood / adolescent onset group 
[29-33]. These studies have reported a higher prevalence of 
co-morbid PD [29, 30] and anxiety [29], a poorer response to 
treatment [29], more atypical features [31], higher levels of 
suicidal ideation [33], and more frequent family history of 
mood disorders [29, 31] among patients with early onset 
compared to later onset of depression. Further, the group of 
patients with onset of depression before the age of 25-35 
years seems to be characterized by female gender [32, 33] 
and more severe and recurrent courses of illness [29, 31, 32]. 
However, all of the above-mentioned studies included pre-
adult depressions in the early onset group, hence it is diffi-
cult to determine, how far the characteristics of this age 
group derived from patients with childhood or adolescent 
depression or from patients with early adult depression. Only 
one large study [12] has divided the age of onset further into 
pre-adult (age < 18 years), early adult (age 18-44), middle 
adult (45-59) and late adult (age 60 +). In this study, there 
were fewer clinical differences between the adult age groups 
than between pre-adult and adult depression, though the 
authors still found early adult onset depression to be associ-
ated with higher family loading for affective disorders, more 
prevalent co-morbid anxiety and greater symptom severity 
and suicidal ideation as compared to those with middle and 
late adult onset. This might be due to the exclusion of pa-
tients with pre-adult onset from the early adult group, or it 
could be a consequence of the rather broad age category de-
fining early adult depression compared to other studies. We 
did not replicate the findings of a poorer treatment outcome, 
increased suicidality and greater family loading of affective 
disorder among patients with early onset. There may be sev-
eral reasons for these discrepancies between our findings and 
findings from other studies. Firstly, treatment outcome and 
suicidal ideations assessed in previous studies relate to the 
index episode and not exclusively to the first episode as in 
the present study. Secondly, it seems that these characteris-
tics are general terms of illness severity, which are probably 
associated with a higher risk of recurrence of chronicity. 
Thus, previous findings might be a consequence of selection 
bias (individuals with early onset have a higher probability 
of being enrolled in studies performed many years later, if 
they have a chronic course or many recurrences). Thirdly, 
the results might be confounded by current age and the his-
tory of depression among participants (the clinical appear-
ance of the depressive episodes might chance during the 
course of repeated episodes or with increasing age [34]. This 
explanation is further supported by a large study of age dif-
ferences, in which objective severity scale scores increased 
with  current age, whereas severity was not influenced by 
age-of-onset [6]. Otherwise our results were consistent with 
previous studies regarding co-morbid PD, anxiety, atypical 
features, and gender. The prevalence of SLE has been inves-
tigated in one study by means of self-report questionnaires 
(cut-off age 25 years), finding no difference between patients 
with early and late onset depression [29]. Besides using 
questionnaires instead of interviews, patients with melan-
cholic depression were excluded, which might also have 
influenced the prevalence of SLE among the participants. No 
other study has evaluated SLE in age groups comparable to 
the present study, but assessment of SLE in late-life depres-
sion as compared to depression with earlier onset have pro-
vided divergent results [8, 35].  
CONCLUSION 
 Patients with onset of depression in the early adult age 
(18-30 years) were characterised by a higher level of neu-
roticism and a higher prevalence of co-morbid PD and they 
had less often experienced SLE prior to onset compared to 
individuals experiencing the first depression at a later age 
(31-70 years). The results point to aetiological divergences 
not only between the extreme age groups such as childhood 
and geriatric depressions (genetic susceptibility versus vas-
cular brain pathology), but also between early adult and late 
adult onset depressions (personality factors versus environ-
mental factors). 
ABBREVIATIONS 
ATHF  =  Antidepressant Treatment History Form 
B =  Correlation  Coefficient 
BDI 21  =  Beck Depression Inventory (21 item) 
CI =  Confidence  Interval 
DSM-IV  =  Diagnostic and Statistical Manual of Men-
tal Disorders, Fourth Edition 
EAD  =  Early Adult Depression 
EPQ  =  Eysenck Personality Questionnaire 
Ham-D 17  =  Hamilton Rating Scale of Depression (17 
item) 
ICD-10  =  The International Classification of Dis-
eases, 10th Revision 
IRLE  =  Interview of Recent Life Events 
LAD =  Late  Adult  Depression 
OR =  Odds  Ratio 
PD =  Personality  Disorder Early and Late Onset Adult Depression  Clinical Practice & Epidemiology in Mental Health, 2011, Volume 7     147 
SCAN  =  Schedules for Clinical Assessment in Neu-
ropsychiatry 
SCID II  =  Structured Clinical Interview for DSM-IV 
axis II personality disorders 
SD =  Standard  Deviation 
SLE  =  Stressful Life Event 
SPSS  =  Statistical Package for the Social Sciences 
WHO  =  World Health Organization 
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